$145.54
0.16% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US7599161095
Symbol
RGEN

Repligen Corporation Stock price

$145.54
-4.45 2.97% 1M
+18.95 14.97% 6M
-34.26 19.05% YTD
-38.17 20.78% 1Y
-122.32 45.67% 3Y
+53.31 57.80% 5Y
+126.10 648.66% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.24 0.16%
ISIN
US7599161095
Symbol
RGEN
Sector
Industry

Key metrics

Market capitalization $8.15b
Enterprise Value $8.04b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 61.27
EV/Sales (TTM) EV/Sales 12.70
P/S ratio (TTM) P/S ratio 12.87
P/B ratio (TTM) P/B ratio 4.04
Revenue growth (TTM) Revenue growth -2.91%
Revenue (TTM) Revenue $633.51m
EBIT (operating result TTM) EBIT $27.79m
Free Cash Flow (TTM) Free Cash Flow $131.26m
Cash position $783.96m
EPS (TTM) EPS $-0.15
P/E forward 508.44
P/S forward 12.86
EV/Sales forward 12.68
Short interest 6.89%
Show more

Is Repligen Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Repligen Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Repligen Corporation forecast:

13x Buy
72%
5x Hold
28%

Analyst Opinions

18 Analysts have issued a Repligen Corporation forecast:

Buy
72%
Hold
28%

Financial data from Repligen Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
634 634
3% 3%
100%
- Direct Costs 344 344
4% 4%
54%
290 290
2% 2%
46%
- Selling and Administrative Expenses 132 132
20% 20%
21%
- Research and Development Expense 41 41
5% 5%
7%
116 116
18% 18%
18%
- Depreciation and Amortization 89 89
17% 17%
14%
EBIT (Operating Income) EBIT 28 28
58% 58%
4%
Net Profit -8.10 -8.10
108% 108%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Repligen Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Repligen Corporation Stock News

Neutral
PRNewsWire
13 days ago
BOTHELL, Wash. , Dec. 16, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS ) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the appointment of Tony J.
Neutral
GlobeNewsWire
17 days ago
WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2023 Corporate Sustainability Report and related reporting framework disclosures. Themed “Advancing Impacts”, this newly reformatted report streamlines the company's progress in advancing our ...
Neutral
GlobeNewsWire
20 days ago
Breakthrough Innovation for the Purification of mRNA Therapeutics and Vaccines Breakthrough Innovation for the Purification of mRNA Therapeutics and Vaccines
More Repligen Corporation News

Company Profile

Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Head office United States
CEO Olivier Loeillot
Employees 1,783
Founded 1981
Website www.repligen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today